×
ADVERTISEMENT

non-nucleoside reverse transcriptase inhibitor

HIV Drugs in the Pipeline: Expected Approvals for 2018

Pharmaceutical companies are looking at antiretroviral therapy regimens that are easier on patients with HIV.

FEBRUARY 7, 2018

Load more